Skip to main navigation Skip to search Skip to main content

Characterisation of the biosynthetic pathway to agnestins A and B reveals the reductive route to chrysophanol in fungi

  • Agnieszka J. Szwalbe
  • , Katherine Williams
  • , Zhongshu Song
  • , Kate De Mattos-Shipley
  • , Jason L. Vincent
  • , Andrew M. Bailey
  • , Christine L. Willis
  • , Russell J. Cox
  • , Thomas J. Simpson*
  • *Corresponding author for this work

Research output: Contribution to journalArticle (Academic Journal)peer-review

50 Citations (Scopus)
304 Downloads (Pure)

Abstract

Two new dihydroxy-xanthone metabolites, agnestins A and B, were isolated from Paecilomyces variotii along with a number of related benzophenones and xanthones including monodictyphenone. The structures were elucidated by NMR analyses and X-ray crystallography. The agnestin (agn) biosynthetic gene cluster was identified and targeted gene disruptions of the PKS, Baeyer-Villiger monooxygenase, and other oxido-reductase genes revealed new details of fungal xanthone biosynthesis. In particular, identification of a reductase responsible for in vivo anthraquinone to anthrol conversion confirms a previously postulated essential step in aromatic deoxygenation of anthraquinones, e.g. emodin to chrysophanol.

Original languageEnglish
Pages (from-to)233-238
Number of pages6
JournalChemical Science
Volume10
Issue number1
DOIs
Publication statusPublished - 7 Jan 2019

Research Groups and Themes

  • BrisSynBio
  • Bristol BioDesign Institute
  • Organic & Biological

Keywords

  • synthetic biology
  • Synthetic Biology

Fingerprint

Dive into the research topics of 'Characterisation of the biosynthetic pathway to agnestins A and B reveals the reductive route to chrysophanol in fungi'. Together they form a unique fingerprint.

Cite this